These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38688879)

  • 1. Combining neuropsychological assessment and structural neuroimaging to identify early Alzheimer's disease in a memory clinic cohort.
    Quek YE; Fung YL; Bourgeat P; Vogrin SJ; Collins SJ; Bowden SC
    Brain Behav; 2024 May; 14(5):e3505. PubMed ID: 38688879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T2 Relaxometry and Diffusion Tensor Indices of the Hippocampus and Entorhinal Cortex Improve Sensitivity and Specificity of MRI to Detect Amnestic Mild Cognitive Impairment and Alzheimer's Disease Dementia.
    Knight MJ; Wearn A; Coulthard E; Kauppinen RA
    J Magn Reson Imaging; 2019 Feb; 49(2):445-455. PubMed ID: 30209854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Alteration of Medial Temporal Lobe Subfield in the Amnestic Mild Cognitive Impairment Stage of Alzheimer's Disease.
    He P; Qu H; Cai M; Liu W; Gu X; Ma Q
    Neural Plast; 2022; 2022():8461235. PubMed ID: 35111220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive Impairment.
    Suppa P; Hampel H; Kepp T; Lange C; Spies L; Fiebach JB; Dubois B; Buchert R;
    J Alzheimers Dis; 2016; 51(3):867-73. PubMed ID: 26923010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-modal MRI investigation of volumetric and microstructural changes in the hippocampus and its subfields in mild cognitive impairment, Alzheimer's disease, and dementia with Lewy bodies.
    Mak E; Gabel S; Su L; Williams GB; Arnold R; Passamonti L; Vazquez Rodríguez P; Surendranathan A; Bevan-Jones WR; Rowe JB; O'Brien JT
    Int Psychogeriatr; 2017 Apr; 29(4):545-555. PubMed ID: 28088928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Odor identification deficit in mild cognitive impairment and Alzheimer's disease is associated with hippocampal and deep gray matter atrophy.
    Hagemeier J; Woodward MR; Rafique UA; Amrutkar CV; Bergsland N; Dwyer MG; Benedict R; Zivadinov R; Szigeti K
    Psychiatry Res Neuroimaging; 2016 Sep; 255():87-93. PubMed ID: 27567325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.
    Fleisher AS; Sun S; Taylor C; Ward CP; Gamst AC; Petersen RC; Jack CR; Aisen PS; Thal LJ
    Neurology; 2008 Jan; 70(3):191-9. PubMed ID: 18195264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting biological heterogeneity patterns in ADNI amnestic mild cognitive impairment based on volumetric MRI.
    Ezzati A; Zammit AR; Habeck C; Hall CB; Lipton RB;
    Brain Imaging Behav; 2020 Oct; 14(5):1792-1804. PubMed ID: 31104279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Profile of Incidental Memory in Patients with Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Kontaxopoulou D; Beratis IN; Fragkiadaki S; Pavlou D; Andronas N; Yannis G; Economou A; Papanicolaou AC; Papageorgiou SG
    J Alzheimers Dis; 2018; 65(2):617-627. PubMed ID: 30056423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between fully automated MRI-based volumetry of different brain regions and neuropsychological test performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Arlt S; Buchert R; Spies L; Eichenlaub M; Lehmbeck JT; Jahn H
    Eur Arch Psychiatry Clin Neurosci; 2013 Jun; 263(4):335-44. PubMed ID: 22940716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter integrity disruption in the pre-dementia stages of Alzheimer's disease: from subjective memory impairment to amnestic mild cognitive impairment.
    Shao W; Li X; Zhang J; Yang C; Tao W; Zhang S; Zhang Z; Peng D
    Eur J Neurol; 2019 May; 26(5):800-807. PubMed ID: 30584694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Hippocampal Volume and African Neuropsychology Memory Tests in Adult Individuals with Probable Alzheimer's Disease in Democratic Republic of Congo.
    Ikanga J; Hickle S; Schwinne M; Epenge E; Gikelekele G; Kavugho I; Tsengele N; Samuel M; Zhao L; Qiu D; Stringer A; Saindane AM; Alonso A; Drane DL
    J Alzheimers Dis; 2023; 96(1):395-408. PubMed ID: 37781799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroimaging basis in the conversion of aMCI patients with APOE-ε4 to AD: study protocol of a prospective diagnostic trial.
    Chen GQ; Sheng C; Li YX; Yu Y; Wang XN; Sun Y; Li HY; Li XY; Xie YY; Han Y
    BMC Neurol; 2016 May; 16():64. PubMed ID: 27176479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between visual association memory test and structural changes in patients with Alzheimer's disease and amnestic mild cognitive impairment.
    Huang KL; Hsiao IT; Kuo HC; Hsieh CJ; Hsieh YC; Wu YM; Wey SP; Yen TC; Lin KJ; Huang CC
    J Formos Med Assoc; 2019 Sep; 118(9):1325-1332. PubMed ID: 30579663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Entorhinal Tau Predicts Hippocampal Activation and Memory Deficits in Alzheimer's Disease.
    Richter N; Bischof GN; Dronse J; Nellessen N; Neumaier B; Langen KJ; Drzezga A; Fink GR; van Eimeren T; Kukolja J; Onur OA
    J Alzheimers Dis; 2020; 78(4):1601-1614. PubMed ID: 33164934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher Peripheral TREM2 mRNA Levels Relate to Cognitive Deficits and Hippocampal Atrophy in Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    Tan YJ; Ng ASL; Vipin A; Lim JKW; Chander RJ; Ji F; Qiu Y; Ting SKS; Hameed S; Lee TS; Zeng L; Kandiah N; Zhou J
    J Alzheimers Dis; 2017; 58(2):413-423. PubMed ID: 28453482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive/Functional Measures Predict Alzheimer's Disease, Dependent on Hippocampal Volume.
    Tabatabaei-Jafari H; Shaw ME; Walsh E; Cherbuin N
    J Gerontol B Psychol Sci Soc Sci; 2020 Aug; 75(7):1393-1402. PubMed ID: 30668830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered Neuroanatomical Asymmetries of Subcortical Structures in Subjective Cognitive Decline, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease.
    Fu Z; Zhao M; Wang X; He Y; Tian Y; Yang Y; Han Y; Li S
    J Alzheimers Dis; 2021; 79(3):1121-1132. PubMed ID: 33386805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.